Formula Growth’s Pediatrix Medical MD Stock Holding History

Formula Growth’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-10,376	Closed	-$577K	–	151
2018 Q1	$577K	Sell	10,376 -4,000	-28%	-$219K	0.07%	141
2017 Q4	$768K	Hold	14,376	–	–	0.1%	121
2017 Q3	$620K	Hold	14,376	–	–	0.1%	131
2017 Q2	$868K	Sell	14,376 -12,000	-45%	-$711K	0.15%	116
2017 Q1	$1.83M	Hold	26,376	–	–	0.38%	79
2016 Q4	$1.76M	Hold	26,376	–	–	0.41%	74
2016 Q3	$1.75M	Sell	26,376 -3,000	-10%	-$205K	0.4%	83
2016 Q2	$2.13M	Hold	29,376	–	–	0.52%	63
2016 Q1	$1.9M	Hold	29,376	–	–	0.45%	76
2015 Q4	$2.1M	Buy	+29,376	New	+$2.17M	0.49%	70

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Formula Growth's MD Position: Q2 2018 in Review

Formula Growth sold out of Pediatrix Medical (MD) in Q2 2018, closing a stake of 10,376 shares — an estimated $577K sold.

Formula Growth first reported a position in MD in Q4 2015 and held it in 10 quarters. The position peaked at $2.13M in Q2 2016. 322 funds tracked by Wall St. Rank hold MD as of Q2 2018.

Formula Growth reported no remaining Pediatrix Medical position as of Q2 2018 after selling out during the quarter.
Formula Growth sold 10,376 Pediatrix Medical shares in Q2 2018, an estimated $577K.
Formula Growth first reported a position in Pediatrix Medical in Q4 2015 and held it in 10 quarters.
Formula Growth's Pediatrix Medical position peaked at $2.13M in Q2 2016.
322 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2018.

Based on Formula Growth's 13F filing for Q2 2018, filed 13 Aug 2018.